Aller au contenu principal
Profil bibliographique

Hope L. O'Brien

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

6Publications signalées
16Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Migraine and Headache StudiesBotulinum Toxin and Related Neurological DisordersNeurological Complications and SyndromesUrinary Bladder and Prostate ResearchSuicide and Self-Harm Studies

Les publications récentes

Accès ouvert 2026 article OpenAlex

Efficacy and safety of rimegepant for the acute treatment of migraine in Black or African American adults: A post hoc pooled subgroup analysis from three randomized, placebo‐controlled clinical trials

Larry Iv Charleston, Cynthia Armand, Teshamae Monteith, Hope L. O'Brien et autres

OBJECTIVE: This post hoc subgroup analysis was conducted using pooled data from three US-based clinical trials to compare efficacy and safety of rimegepant 75 mg versus placebo in acute migraine in adults who are Black or African American. BACKGROUND: Migraine, characterized by …

us (code pays fourni par la source)

1 citation Headache The Journal of Head and Face Pain
Accès ouvert 2026 article OpenAlex

Central and Peripheral Sensitization in Temporomandibular Disorders: Proposed Mechanisms of Botulinum Toxin Therapy

Basit Ali Chaudhry, Christopher Louis Robinson, Edoardo Caronna, Freda Dodd-Glover et autres

Temporomandibular disorders (TMDs) are common musculoskeletal chronic orofacial pain conditions involving peripheral and central sensitization within trigeminal nociceptive pathways, manifesting as mechanical allodynia and functional impairment. Botulinum toxin type A (BoNT-A) has been explored as a treatment targeting both muscle hyperactivity and …

dk, us, es, Ghana, br (code pays fourni par la source)

8 citations Toxins
Accès ouvert 2025 article OpenAlex

OnabotulinumtoxinA treatment among diverse racial groups: Post hoc analysis of the phase 4 Chronic migraine OnabotulinuMtoxinA Prolonged Efficacy open‐Label ( COMPEL ) trial

Andrew M. Blumenfeld, Larry Iv Charleston, Deena E. Kuruvilla, Belinda Savage‐Edwards et autres

OBJECTIVE: Examine treatment responses to and safety of onabotulinumtoxinA for the preventive treatment of chronic migraine (CM) among diverse racial groups. BACKGROUND: Evidence suggests there are differences in headache treatment patterns, symptom profiles, and burden based on race. However, limited data are …

us (code pays fourni par la source)

1 citation Headache The Journal of Head and Face Pain
Accès ouvert 2025 article OpenAlex

Routine migraine screening as a standard of care for Women's health: A position statement from the American Headache Society

Todd J. Schwedt, Amaal Jilani Starling, Jessica Ailani, Andrew D. Hershey et autres

OBJECTIVES: The aim of this work was to develop an American Headache Society position statement addressing diagnostic screening for migraine among girls and women. BACKGROUND: Despite its high prevalence and substantial negative impacts, migraine is underdiagnosed and undertreated. Diagnostic screening for migraine …

us (code pays fourni par la source)

0 citations Headache The Journal of Head and Face Pain
Accès ouvert 2024 article OpenAlex

Clinic-Based Characterization of Adolescents and Young Adults With Migraine

Robert C. Gibler, Maya A. Marzouk, James Peugh, Brooke L. Reidy et autres

Background and Objectives: This cross-sectional observational study retrospectively examined clinical data collected from adolescents and young adults (AYAs) seeking care in a specialty headache clinic. We characterized participants' headache characteristics and psychological functioning and examined the association between self-reported anxiety and depressive …

us (code pays fourni par la source)

6 citations Neurology Clinical Practice
2014 article OpenAlex

Verhaltenstherapie + Amitriptylin bei kindlicher Migräne

S W Powers, S Kashikar-Zuck, J. R. Allen, Susan L. LeCates et autres

Den Nutzen von kognitiver Verhaltenstherapie (KVT) und Amitriptylin einerseits im Vergleich zu Amitriptylin und edukativen Maßnahmen (EM) andererseits untersuchte die Arbeitsgruppe um S. Powers von der Abteilung für Verhaltenstherapie und klinische Psychologie des Kinderkrankenhauses von Cincinnati in Ohio. Sie zeigten, dass KVT …

0 citations Journal Club Schmerzmedizin

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.